AzTrials
AzTrials

Older Adults (65 Years and Older)NCT07248293

"Income Level and Its Effect in Older Adults"

An observational study of Older Adults (65 Years and Older), run by Begüm AKAR at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of this study was to examine the effect of income level on cognitive function, pain, balance, lower extremity performance, gait, occupational competence, depression, and health-promoting behaviors in older adults. Read more about this study

Who is it for?
Ages 65 to 85 yearsHealthy volunteers can take part
Conditions the study is for
Older Adults (65 Years and Older)
What is being tested?
Behavioral Treatment and behavioral
How many people
223 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Jan 2025to 15 Sep 2025
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 to 85 years
  • All sexes
  • Healthy volunteers accepted
  • Older adult

Study population: elderly

Who may be able to join

  • Being 65 years of age or older
  • Volunteering to participate in the study
  • Elderly individuals scoring 6 or higher on the Hodkinson Mental Test

Who cannot join

  • Elderly individuals who cannot communicate due to conditions such as Alzheimer's disease, dementia, or psychosis
  • Having another chronic disease that may cause pain (rheumatic diseases, hemiplegia, multiple sclerosis, diabetes, etc.)
  • Having a neurological disease (hemiplegia, Parkinson's disease, multiple sclerosis, vertigo, epilepsy, etc.)
  • Being blind
  • Having orthopedic, neurological, or mental disabilities

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Pamukkale University

    Pamukkale, Denizli, 20000

Other trials in Turkey (Türkiye)

About this study

Official title: "Investigation of the Effect of Income Level in Older Adults: A Randomized Controlled Trial"

The aim of this study was to examine the effect of income level on cognitive function, pain, balance, lower extremity performance, gait, occupational competence, depression, and health-promoting behaviors in older adults.

Being tested
Behavioral Treatment, behavioral
Keywords
older adults

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Behavioral TreatmentOther

    What makes this study different is that participants are categorized according to income levels, and detailed analyses are conducted between the subgroups.

  • behavioralBehavioural

    The difference between this study and other studies is that in this study, the elderly are categorized according to their income levels.

Study groups in NCT07248293
Study groupRoleWhat they receive
minimum wageMinimum Wage Group: The elderly in this group consist of older adults earning a minimum wage.
Receives: Other: Behavioral Treatment; Behavioral: behavioral
above minimum wage groupAbove Minimum Wage Group: The elderly in this group consist of older adults whose income levels are above the minimum wage threshold.
Receives: Other: Behavioral Treatment; Behavioral: behavioral

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Mini-Mental State Examination (MMSE):

    Mini-Mental State Examination (MMSE):

    The Mini-Mental State Examination is a scale used to assess individuals' cognitive status. It evaluates attention, orientation, memory, the ability to follow verbal and written commands, spontaneous writing, and copying complex drawings. The total score is 30, with a cutoff point of 24; scores below 24 indicate cognitive impairment. The Turkish validity and reliability study was conducted by Güngen et al. in 2002

    Measured: 10 minutes

  2. Hodkinson mental test

    The Hodkinson Mental Test was developed by H.M. Hodkinson in 1972 and is used to assess cognitive functions in older adults. The test consists of 10 questions in total, with each correct answer worth 1 point. Scores below 7 indicate cognitive impairment. The test can be completed in less than 5 minutes and is a short, easy-to-administer tool that does not include culturally specific questions .

    Measured: 10 minutes

  3. Dominant Side Single-Leg Stance Test

    Dominant Side Single-Leg Stance Test:

    In this test, if the participant uses a walking aid, timing starts when they lift their dominant leg and release the aid; if not, timing begins when the dominant leg is lifted. The test ends when the foot touches the ground. If the participant can balance for more than 30 seconds, the test is completed. The duration is recorded in seconds. A result of less than 10 seconds indicates balance impairment, and less than 5 seconds indicates a risk of falling (17).

    Measured: 1 minutes

  4. Sit-to-Stand Test

    Sit-to-Stand Test:

    The participant, seated on a standard 43 cm-high chair with arms crossed over the shoulders, is asked to stand up and sit down as quickly as possible for 30 seconds. The number of full stands completed is recorded.

    Measured: 2 minutes

  5. Modified Gait Efficacy Scale (MGES):

    Modified Gait Efficacy Scale (MGES):

    The Modified Gait Efficacy Scale (MGES) is an adaptation of the original Gait Efficacy Scale (GES) used to assess an individual's confidence in walking safely and effectively. The MGES includes several questions measuring participants' confidence in various walking activities. These questions are typically answered on a Likert-type scale (e.g., 0 to 10), where 0 represents the lowest confidence and 10 represents the highest confidence (26).

    Measured: 3 minutes

Secondary outcomes (3)
  1. Geriatric Pain Scale

    The Geriatric Pain Scale, developed by Ferrell BA and colleagues in 2000, is a 24-item multidimensional scale. It assesses five dimensions: pain-related withdrawal (items 6, 17, 18, 19, 20, 21, 24), pain intensity (items 1, 2, 3, 4, 5, 22, 23), pain with movement (items 9, 10, 11, 12), pain during strenuous activities (items 8, 13, 14), and pain during other activities (items 7, 15, 16, 17, 22). Twenty-two items are scored as "Yes" or "No," and 2 items are scored on a 0-10 scale. Total scores range from 0 to 100, with 0-30 indicating mild pain, 30-69 moderate pain, and 70 or above severe pain (31). The Turkish validity and reliability study was conducted by Dursun and Bektas (2017). The Cronbach's alpha for the entire scale was 0.85, with subscale alpha values ranging from 0.67 to 0.93 (19).

    Measured: 5 minutes

  2. Yesavage Geriatric Depression Scale (GDS) - Short Form:

    Yesavage Geriatric Depression Scale (GDS) - Short Form:

    The Yesavage Geriatric Depression Scale, developed in 1983, assesses depressive mood in older adults and is self-reported. The 15-item short form, validated in Turkish, scores depression-related items as 1 and non-depression items as 0, with five items reverse-scored (items 1, 5, 7, 11, 13). Scores range from 0 to 15, with higher scores indicating greater depressive symptoms. The cutoff point is 5. The scale has high internal consistency, with a Cronbach's alpha of 0.92.

    Measured: 10 minutes

  3. Occupational Self Assessment (OSA) Scale:

    The Occupational Self Assessment (OSA) Version 2.2 was used to evaluate individuals' occupational competence. Participants rate how well they perform 21 activities on a scale from 1 (I have a lot of difficulty doing this) to 4 (I do this extremely well) and the importance of these activities from 1 (Not important to me) to 4 (Extremely important to me). After answering the competence (Step 1) and value (Step 2) questions, participants select the areas they most want to change (Step 3) (27,28).

    Measured: 5 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Nov 2025
  2. Study start1 Jan 2025
  3. Primary completion15 Aug 2025
  4. Study completion15 Sep 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Cross-sectional
Enrolment
223 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07248293
Sponsor's protocol ID
Pamukkale U
Status last verified
Nov 2025
First submitted
18 Nov 2025
Last updated
25 Nov 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Older Adults (65 Years and Older), run by Begüm AKAR at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 25 Nov 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Mini-Mental State Examination (MMSE): (time frame: 10 minutes). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Nov 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in